Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-23-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to establish a Coordination and Data Sharing Center (CDSC) in support of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers. Together, the CDSC and ReVAMPP Centers will form the ReVAMPP Network. The purpose of the CDSC is to support, coordinate, and manage ongoing and planned activities within the ReVAMPP Network. The CDSC is expected to establish and maintain a col...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 16, 2023 Category: Research Source Type: funding
Cyber Safety & COVID-19
The current outbreak of the novel coronavirus (COVID-19) has introduced new cybersecurity risks both at NIH and across the globe. As targeted phishing attacks prey on our desire to access trustworthy information and many of us make a shift toward remote work, we all need to be vigilant and take accountability for cyber safety.
Be
Vigilant – Protect Against Phishing Attacks
Phishing attacks related to
COVID-19 are on the rise. Over the past few weeks, several federal agencies and
international organizations, including the World Health Organization, have
issued cybersecurity
alerts about criminal groups who are e...
Source: NIH Extramural Nexus - April 17, 2020 Category: Research Authors: NIH Cyber Safety Campaign Team Tags: blog Open Mike coronavirus COVID19 cybersecurity Source Type: funding
Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required)
Funding Opportunity PAR-19-236 from the NIH Guide for Grants and Contracts. Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Unfortunately, numerous studies find a substantial delay between the onset of psychotic symptoms and the initiation of FEP care; in the U.S. treatment is typically delayed between one and ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 2, 2019 Category: Research Source Type: funding
Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required)
Funding Opportunity PAR-19-235 from the NIH Guide for Grants and Contracts. Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Unfortunately, numerous studies find a substantial delay between the onset of psychotic symptoms and the initiation of FEP care; in the U.S. treatment is typically delayed between one and ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 2, 2019 Category: Research Source Type: funding
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
Funding Opportunity PAR-19-153 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 1224 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and car...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2019 Category: Research Source Type: funding
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)
Funding Opportunity PAR-19-136 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 1224 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and car...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2018 Category: Research Source Type: funding
Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required)
Funding Opportunity PAR-18-233 from the NIH Guide for Grants and Contracts. Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Compared to traditional treatment approaches, programs that integrate pharmacologic, psychological, and rehabilitation interventions for FEP, i.e., team-based Coordinated Specialty Care (C...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2017 Category: Research Source Type: funding
Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required)
Funding Opportunity PAR-18-232 from the NIH Guide for Grants and Contracts. Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Compared to traditional treatment approaches, programs that integrate pharmacologic, psychological, and rehabilitation interventions for FEP, i.e., team-based Coordinated Specialty Care (C...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2017 Category: Research Source Type: funding
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
Funding Opportunity PA-18-155 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12 24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and car...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2017 Category: Research Source Type: funding
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)
Funding Opportunity PA-18-137 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12 24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and car...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2017 Category: Research Source Type: funding
Building Research Capacity in Global Tobacco Product Regulation Program (U18)
Funding Opportunity RFA-FD-18-003 from the NIH Guide for Grants and Contracts. The Food and Drug Administration announces its intention to accept and consider a single source application for award to the World Health Organization (WHO) for the Building Research Capacity in Global Tobacco Product Regulation Program. The purpose of the Program is to identify, support, develop, conduct, and coordinate research efforts relating to tobacco control laws and rules in foreign countries that will directly inform and support FDAs exercise of its authority to regulate the manufacture, distribution, marketing and sale of tobacco pr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 20, 2017 Category: Research Source Type: funding
Identification of Target Peptide Sequences for Zika IgM Diagnostic Device
Funding Opportunity ID: 292882 Opportunity Number: RFA-FD-17-002 Opportunity Title: Identification of Target Peptide Sequences for Zika IgM Diagnostic DeviceOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: AgricultureConsumer ProtectionFood and NutritionCategory Explanation: CFDA Number(s): 93.103Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: The following organization is eligible to apply: PEPperPrint GmbHA...
Source: Grants.gov - March 31, 2017 Category: Research Tags: Agriculture Consumer Protection Food and Nutrition Source Type: funding
Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017)
Funding Opportunity ID: 292838 Opportunity Number: CDC-RFA-CK13-1301 Opportunity Title: Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.099Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Pan American Health Organizati...
Source: Grants.gov - March 29, 2017 Category: Research Tags: Health Source Type: funding
Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization.
Funding Opportunity ID: 292186 Opportunity Number: CDC-RFA-IP16-160702CONT17 Opportunity Title: Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization.Opportunity Category: ContinuationOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.318Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: This award will be a continuation of funds intended only...
Source: Grants.gov - March 3, 2017 Category: Research Tags: Health Source Type: funding
Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization.
Funding Opportunity ID: 292168 Opportunity Number: CDC-RFA-IP16-160602CONT17 Opportunity Title: Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization.Opportunity Category: ContinuationOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.318Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: This award will be a continuation of funds intended only...
Source: Grants.gov - March 3, 2017 Category: Research Tags: Health Source Type: funding
